Erik Björk

3.0k total citations
57 papers, 2.4k citations indexed

About

Erik Björk is a scholar working on Surgery, Pharmaceutical Science and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Erik Björk has authored 57 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 20 papers in Pharmaceutical Science and 18 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Erik Björk's work include Diabetes and associated disorders (18 papers), Pancreatic function and diabetes (18 papers) and Advanced Drug Delivery Systems (17 papers). Erik Björk is often cited by papers focused on Diabetes and associated disorders (18 papers), Pancreatic function and diabetes (18 papers) and Advanced Drug Delivery Systems (17 papers). Erik Björk collaborates with scholars based in Sweden, United States and India. Erik Björk's co-authors include Peter Edman, Maria Dahlin, F. Anders Karlsson, Per Artursson, Johan Gråsjö, Olle Kämpe, Per Artursson, Ola Camber, Christian Berne and Katarina Edsman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Clinical Endocrinology & Metabolism and Advanced Drug Delivery Reviews.

In The Last Decade

Erik Björk

57 papers receiving 2.3k citations

Peers

Countries citing papers authored by Erik Björk

Since Specialization

Citations

This map shows the geographic impact of Erik Björk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Björk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Björk more than expected).

Fields of papers citing papers by Erik Björk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Björk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Björk. The network helps show where Erik Björk may publish in the future.

Co-authorship network of co-authors of Erik Björk

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Björk. A scholar is included among the top collaborators of Erik Björk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Björk. Erik Björk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Proinsulin/C‐peptide ratio, glucagon and remission in new‐onset Type 1 diabetes mellitus in young adults 2010 ·Diabetic Medicine ·Anna Schölin, L. Nyström, Hans J. Arnqvist, Jan Bolinder, Erik Björk, Christian Berne, F. Anders Karlsson, (unknown)	33
2	Clinical Study Shows Improved Absorption of Desmopressin with Novel Formulation 2009 ·Pharmaceutical Research ·(unknown), Susanne Bredenberg, Erik Björk	28
3	Development and characterisation of interactive mixtures with a fine-particulate mucoadhesive carrier for nasal drug delivery 2007 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown), Erik Björk, Christer Nyström	19
4	Direct Nose-to-Brain Transfer of Morphine After Nasal Administration to Rats 2006 ·Pharmaceutical Research ·Ulla Westin, Emma Boström, Johan Gråsjö, Margareta Hammarlund‐Udenaes, Erik Björk	64
5	Hyperproinsulinemia segregates young adult patients with newly diagnosed autoimmune (type 1) and non‐autoimmune (type 2) diabetes 2005 ·Scandinavian Journal of Clinical and Laboratory Investigation ·Jan Bolinder, Per Fernlund, (unknown), H. J. Arnqvist, Erik Björk, G. Blohmé, (unknown), L. Nyström, Jan‐Ola Östman, G. Sundkvist	6
6	Correlation Between Epithelial Toxicity and Surfactant Structure as Derived From the Effects of Polyethyleneoxide Surfactants on Caco-2 Cell Monolayers and Pig Nasal Mucosa 2005 ·Journal of Pharmaceutical Sciences ·Katarina Ekelund, (unknown), (unknown), Erik Björk, Stefan Ulvenlund, Fredrik Johansson	33
7	Normal weight promotes remission and low number of islet antibodies prolong the duration of remission in Type 1 diabetes 2004 ·Diabetic Medicine ·Anna Schölin, Carina Törn, L. Nyström, C Berne, H. J. Arnqvist, G. Blohmé, Jan Bolinder, (unknown), Ingrid Kockum, Mona Landin‐Olsson, Jan Östman, F. Anders Karlsson, G. Sundkvist, Erik Björk	32
8	Permeability of porcine nasal mucosa correlated with human nasal absorption 2003 ·European Journal of Pharmaceutical Sciences ·(unknown), Erik Björk, Ola Camber	41
9	Increasing body mass index at diagnosis of diabetes in young adult people during 1983–1999 in the Diabetes Incidence Study in Sweden (DISS) 2003 ·Journal of Internal Medicine ·Bengt Littorin, L. Nyström, Bo Gullberg, L. Råstam, Jan Östman, Hans J. Arnqvist, Erik Björk, G. Blohmé, Jan Bolinder, Jan W. Eriksson, Bengt Scherstén, G. Sundkvist	7
10	Islet antibodies at diagnosis versus beta-cell function eight years later in young adult patients with diabetes. 2002 ·Diabetologia ·(unknown), (unknown), Håkan Borg, H. J. Arnqvist, Erik Björk, G. Blohmé, Jan Bolinder, (unknown), L. Nyström, Jan‐Ola Östman, G. Sundkvist	2
11	The incidence of Type I diabetes has not increased but shifted to a younger age at diagnosis in the 0–34 years group in Sweden 1983 to 1998 2002 ·Diabetologia ·(unknown), Austė Pundziūtė-Lyckå, Gisela Dahlquist, L. Nyström, Hans J. Arnqvist, Erik Björk, G. Blohmé, Jan Bolinder, Jan W. Eriksson, G. Sundkvist, Jan Östman	172
12	Visualization of In Vivo Olfactory Uptake and Transfer Using Fluorescein Dextran 2002 ·Journal of drug targeting ·Birgitta Jansson, Erik Björk	58
13	Levels of dopamine in blood and brain following nasal administration to rats 2001 ·European Journal of Pharmaceutical Sciences ·Maria Dahlin, (unknown), Erik Björk	78
14	Nasal absorption of (S)-UH-301 and its transport into the cerebrospinal fluid of rats 2000 ·International Journal of Pharmaceutics ·Maria Dahlin, Erik Björk	36
15	Nasal drug delivery – evaluation of an in vitro model using porcine nasal mucosa 1999 ·European Journal of Pharmaceutical Sciences ·(unknown), Erik Björk, Ola Camber	60
16	Factors predicting clinical remission in adult patients with type 1 diabetes 1999 ·Journal of Internal Medicine ·Anna Schölin, Christian Berne, E. Schvarcz, F. Anders Karlsson, Erik Björk	46
17	The Influence of Intestinal Mucus Components on the Diffusion of Drugs 1998 ·Pharmaceutical Research ·(unknown), Per Artursson, Erik Björk	137
18	Diffusion of Drugs in Native and Purified Gastrointestinal Mucus 1997 ·Journal of Pharmaceutical Sciences ·(unknown), Per Artursson, Johan Gråsjö, Erik Björk	153
19	Starch Microspheres Induce Pulsatile Delivery of Drugs and Peptides Across the Epithelial Barrier by Reversible Separation of the Tight Junctions 1995 ·Journal of drug targeting ·Erik Björk, (unknown), Peter Edman, Per Artursson	56
20	Regulation of GAD expression in islets of Langerhans occurs both at the mRNA and protein level 1994 ·Molecular and Cellular Endocrinology ·Lı́cio A. Velloso, Erik Björk, (unknown), Nina S. Funa, Arne Andersson, Olle Kämpe, F. Anders Karlsson, Décio L. Eizirik	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact